Aldeyra Therapeutics to Host Conference Call & Webcast to Announce Top-Line Results from Part 1 of Adaptive Phase 3 RENEW Tri...

Date : 12/02/2019 @ 9:01PM
Source : Business Wire
Stock : Aldeyra Therapeutics Inc (ALDX)
Quote : 6.29  -0.11 (-1.72%) @ 7:29PM
Aldeyra Therapeutics share price Chart

Aldeyra Therapeutics to Host Conference Call & Webcast to Announce Top-Line Results from Part 1 of Adaptive Phase 3 RENEW Tri...

Aldeyra Therapeutics (NASDAQ:ALDX)
Historical Stock Chart

2 Months : From Nov 2019 to Jan 2020

Click Here for more Aldeyra Therapeutics Charts.

Event scheduled for 8:00 a.m. ET Tuesday, December 3, 2019

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) will host a conference call and webcast at 8:00 a.m. ET Tuesday, December 3, 2019, to provide top-line results from Part 1 of the adaptive Phase 3 RENEW Trial of topical ocular reproxalap in patients with dry eye disease.

The dial-in numbers are (866) 211-4098 for domestic callers and (647) 689-6613 for international callers. The Conference ID is 1592481. A live audio webcast of the conference call will also be available on the Investor Relations section of the Aldeyra Therapeutics website at https://ir.aldeyra.com. Presentation slides will be available on the investor relations page approximately 30 minutes prior to the start of the conference call and webcast.

After the live webcast, the event will remain archived on the Aldeyra Therapeutics website for one year.

About Aldeyra Therapeutics Aldeyra Therapeutics is a biotechnology company devoted to developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. Aldeyra's lead investigational drug product candidates are potential first-in-class treatments in development for dry eye disease, allergic conjunctivitis, proliferative vitreoretinopathy, and Sj√gren-Larsson Syndrome. The company is also developing other product candidates for retinal and systemic inflammatory diseases.

Corporate Contact: David McMullin Aldeyra Therapeutics, Inc. 781-761-4904 ext. 218 dmcmullin@aldeyra.com Investor & Media Contact: Scott Solomon Sharon Merrill Associates, Inc. 617-542-5300 ALDX@investorrelations.com

Latest ALDX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200117 19:46:16